Aversi-Pharma Ltd.
Aversi-Pharma Ltd., a prominent player in the pharmaceutical industry, is headquartered in Georgia (GE) and operates extensively across the region. Founded in 1992, the company has established itself as a leader in the development, manufacturing, and distribution of high-quality pharmaceutical products. Aversi-Pharma is renowned for its diverse portfolio, which includes prescription medications, over-the-counter drugs, and innovative healthcare solutions tailored to meet the needs of patients. With a commitment to excellence, Aversi-Pharma has achieved significant milestones, including the expansion of its production facilities and the introduction of cutting-edge technologies. The company’s unique approach to product development and its focus on quality assurance have solidified its market position, making it a trusted name in the healthcare sector. Aversi-Pharma continues to strive for excellence, contributing to the well-being of communities throughout Georgia and beyond.
DitchCarbon Score
How does Aversi-Pharma Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Aversi-Pharma Ltd.'s score of 16 is higher than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Aversi-Pharma Ltd.'s reported carbon emissions
Aversi-Pharma Ltd., headquartered in Georgia (GE), currently does not have publicly available carbon emissions data for the most recent year, nor does it specify any reduction targets or climate commitments. Without specific emissions figures or defined initiatives, it is challenging to assess their carbon footprint or climate strategy. However, the pharmaceutical industry is increasingly focusing on sustainability and reducing greenhouse gas emissions, indicating a potential commitment to future climate action. Aversi-Pharma may align with industry trends by developing strategies to address climate change, although specific details are not available at this time.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Aversi-Pharma Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
